LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 2 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 2. - Dataset (ID:20310)

 Full screen view
Filter results: >>>>
Cell Small Molecule Small Mol Concentration (uM) Time Point (hr) Total Cell Count Before Treatment Total Cell Count After Treatment Total Control Cell Count Relative Cell Count Normalized Growth Rate Inhibition Value Assay Plate Assay Well
MCF 10A-H2B-mCherry Trametinib
0.31623
 36.54 17.25 866 2679 0.3232 0.7125
MN20160310_N02
D08
MCF 10A-H2B-mCherry Trametinib
0.31623
 36.54 17.25 44 2679 0.0164 0.1373
MN20160310_N02
M17
MCF 10A-H2B-mCherry Trametinib
0.31623
 36.54 17.25 975 2679 0.3638 0.7406
MN20160310_N02
M17
MCF 10A-H2B-mCherry Trametinib
0.31623
 38.51 17.25 746 2906 0.2567 0.6641
MN20160310_N02
D08
MCF 10A-H2B-mCherry Trametinib
0.31623
 38.51 17.25 873 2906 0.3004 0.6999
MN20160310_N02
D08
MCF 10A-H2B-mCherry Trametinib
0.31623
 38.51 17.25 45 2906 0.0155 0.1384
MN20160310_N02
M17
MCF 10A-H2B-mCherry Trametinib
0.31623
 38.51 17.25 862 2906 0.2966 0.6970
MN20160310_N02
M17
MCF 10A-H2B-mCherry Trametinib
0.31623
 40.48 17.25 785 3125 0.2511 0.6635
MN20160310_N02
D08
MCF 10A-H2B-mCherry Trametinib
0.31623
 40.48 17.25 872 3125 0.2790 0.6870
MN20160310_N02
D08
MCF 10A-H2B-mCherry Trametinib
0.31623
 40.48 17.25 47 3125 0.0150 0.1429
MN20160310_N02
M17
MCF 10A-H2B-mCherry Trametinib
0.31623
 40.48 17.25 882 3125 0.2822 0.6896
MN20160310_N02
M17
MCF 10A-H2B-mCherry Trametinib
0.31623
 42.45 17.25 784 3504 0.2237 0.6452
MN20160310_N02
D08
MCF 10A-H2B-mCherry Trametinib
0.31623
 42.45 17.25 871 3504 0.2486 0.6679
MN20160310_N02
D08
MCF 10A-H2B-mCherry Trametinib
0.31623
 42.45 17.25 48 3504 0.0137 0.1428
MN20160310_N02
M17
MCF 10A-H2B-mCherry Trametinib
0.31623
 42.45 17.25 937 3504 0.2674 0.6839
MN20160310_N02
M17
MCF 10A-H2B-mCherry Trametinib
0.31623
 44.42 17.25 808 3895 0.2074 0.6355
MN20160310_N02
D08
MCF 10A-H2B-mCherry Trametinib
0.31623
 44.42 17.25 876 3895 0.2249 0.6525
MN20160310_N02
D08
MCF 10A-H2B-mCherry Trametinib
0.31623
 44.42 17.25 50 3895 0.0128 0.1458
MN20160310_N02
M17
MCF 10A-H2B-mCherry Trametinib
0.31623
 44.42 17.25 989 3895 0.2539 0.6784
MN20160310_N02
M17
MCF 10A-H2B-mCherry Trametinib
0.31623
 46.39 17.25 805 4141 0.1944 0.6258
MN20160310_N02
D08
MCF 10A-H2B-mCherry Trametinib
0.31623
 46.39 17.25 865 4141 0.2089 0.6406
MN20160310_N02
D08
MCF 10A-H2B-mCherry Trametinib
0.31623
 46.39 17.25 51 4141 0.0123 0.1469
MN20160310_N02
M17
MCF 10A-H2B-mCherry Trametinib
0.31623
 46.39 17.25 979 4141 0.2364 0.6665
MN20160310_N02
M17
MCF 10A-H2B-mCherry Trametinib
0.31623
 48.36 17.25 834 4390 0.1900 0.6247
MN20160310_N02
D08
MCF 10A-H2B-mCherry Trametinib
0.31623
 48.36 17.25 868 4390 0.1977 0.6328
MN20160310_N02
D08